Research articles related to the Mycobacterium avium paratuberculosis infections in humans.

Research articles that have investigated the role of the immune system in the manifestation of Crohn's Disease and Ulcerative Colitis.

Links to ongoing clinical trials related to Crohn's Disease or Anti-MAP therapies.  Published data from past trials will be linked to in the appropriate research category.

Research papers related to the detection of MAP, with a primary focus on human detection.


Infliximab (trade name Remicade), is a conventional therapy for Crohn's Disease and Ulcerative Colitis, however, some recent studies have hypothesized a bactericidal effect on MAP.

Genetics plays a role in the development of CD.  Unfortunately, we are just at the beginning of our understanding of the nature of its role.  The papers in this section highlight the current state of that research.

This section captures both Crohn's/MAP related usage as well as other documented uses, since the specific uses of ultraviolet blood irradiation in Crohn's has not been extensively documented.

Secured by RapidSSL